Clinical Trial Update: Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer [Phase 4]

View source ↗

Summary

Clinical trial update indicates withdrawal of a Phase 4 study evaluating metformin to reduce disparities in newly diagnosed breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Woman's | Conditions: Breast Cancer Stage, Insulin Resistance | Phase 4 | Status: WITHDRAWN